ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nesiritide Drug Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-14P12309
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Nesiritide Drug Market Research Report 2022
BUY CHAPTERS

Global Nesiritide Drug Market Research Report 2024

Code: QYRE-Auto-14P12309
Report
May 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bachem
BCN Peptides
Chengdu Kaijie Peptide
China Medical System
Harbin Jixianglong Biotech
Hybio Pharmaceutical
LEAPChem
Suzhou Tianma Pharma

Nesiritide Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nesiritide Drug Market

Nesiritide Drug Market

The global Nesiritide Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nesiritide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nesiritide Drug.

Report Scope

The Nesiritide Drug market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nesiritide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nesiritide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nesiritide Drug Market Report

Report Metric Details
Report Name Nesiritide Drug Market
CAGR 5%
Segment by Type
  • Purity Above or Equal to 99%
  • Purity Below 99%
Segment by Application
  • Treating Decompensated Heart Failure in Adults
  • Treating Decompensated Heart Failure in Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bachem, BCN Peptides, Chengdu Kaijie Peptide, China Medical System, Harbin Jixianglong Biotech, Hybio Pharmaceutical, LeapChem, Suzhou Tianma Pharma, Xiamen Bam Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nesiritide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nesiritide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nesiritide Drug Market report?

Ans: The main players in the Nesiritide Drug Market are Bachem, BCN Peptides, Chengdu Kaijie Peptide, China Medical System, Harbin Jixianglong Biotech, Hybio Pharmaceutical, LeapChem, Suzhou Tianma Pharma, Xiamen Bam Biotech

What are the Application segmentation covered in the Nesiritide Drug Market report?

Ans: The Applications covered in the Nesiritide Drug Market report are Treating Decompensated Heart Failure in Adults, Treating Decompensated Heart Failure in Children

What are the Type segmentation covered in the Nesiritide Drug Market report?

Ans: The Types covered in the Nesiritide Drug Market report are Purity Above or Equal to 99%, Purity Below 99%

1 Nesiritide Drug Market Overview
1.1 Product Overview and Scope of Nesiritide Drug
1.2 Nesiritide Drug Segment by Type
1.2.1 Global Nesiritide Drug Market Value Comparison by Type (2024-2030)
1.2.2 Purity Above or Equal to 99%
1.2.3 Purity Below 99%
1.3 Nesiritide Drug Segment by Application
1.3.1 Global Nesiritide Drug Market Value by Application: (2024-2030)
1.3.2 Treating Decompensated Heart Failure in Adults
1.3.3 Treating Decompensated Heart Failure in Children
1.4 Global Nesiritide Drug Market Size Estimates and Forecasts
1.4.1 Global Nesiritide Drug Revenue 2019-2030
1.4.2 Global Nesiritide Drug Sales 2019-2030
1.4.3 Global Nesiritide Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nesiritide Drug Market Competition by Manufacturers
2.1 Global Nesiritide Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nesiritide Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nesiritide Drug Average Price by Manufacturers (2019-2024)
2.4 Global Nesiritide Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nesiritide Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nesiritide Drug, Product Type & Application
2.7 Nesiritide Drug Market Competitive Situation and Trends
2.7.1 Nesiritide Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nesiritide Drug Players Market Share by Revenue
2.7.3 Global Nesiritide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nesiritide Drug Retrospective Market Scenario by Region
3.1 Global Nesiritide Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nesiritide Drug Global Nesiritide Drug Sales by Region: 2019-2030
3.2.1 Global Nesiritide Drug Sales by Region: 2019-2024
3.2.2 Global Nesiritide Drug Sales by Region: 2025-2030
3.3 Global Nesiritide Drug Global Nesiritide Drug Revenue by Region: 2019-2030
3.3.1 Global Nesiritide Drug Revenue by Region: 2019-2024
3.3.2 Global Nesiritide Drug Revenue by Region: 2025-2030
3.4 North America Nesiritide Drug Market Facts & Figures by Country
3.4.1 North America Nesiritide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nesiritide Drug Sales by Country (2019-2030)
3.4.3 North America Nesiritide Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nesiritide Drug Market Facts & Figures by Country
3.5.1 Europe Nesiritide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nesiritide Drug Sales by Country (2019-2030)
3.5.3 Europe Nesiritide Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nesiritide Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Nesiritide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nesiritide Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Nesiritide Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nesiritide Drug Market Facts & Figures by Country
3.7.1 Latin America Nesiritide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nesiritide Drug Sales by Country (2019-2030)
3.7.3 Latin America Nesiritide Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nesiritide Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Nesiritide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nesiritide Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nesiritide Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nesiritide Drug Sales by Type (2019-2030)
4.1.1 Global Nesiritide Drug Sales by Type (2019-2024)
4.1.2 Global Nesiritide Drug Sales by Type (2025-2030)
4.1.3 Global Nesiritide Drug Sales Market Share by Type (2019-2030)
4.2 Global Nesiritide Drug Revenue by Type (2019-2030)
4.2.1 Global Nesiritide Drug Revenue by Type (2019-2024)
4.2.2 Global Nesiritide Drug Revenue by Type (2025-2030)
4.2.3 Global Nesiritide Drug Revenue Market Share by Type (2019-2030)
4.3 Global Nesiritide Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nesiritide Drug Sales by Application (2019-2030)
5.1.1 Global Nesiritide Drug Sales by Application (2019-2024)
5.1.2 Global Nesiritide Drug Sales by Application (2025-2030)
5.1.3 Global Nesiritide Drug Sales Market Share by Application (2019-2030)
5.2 Global Nesiritide Drug Revenue by Application (2019-2030)
5.2.1 Global Nesiritide Drug Revenue by Application (2019-2024)
5.2.2 Global Nesiritide Drug Revenue by Application (2025-2030)
5.2.3 Global Nesiritide Drug Revenue Market Share by Application (2019-2030)
5.3 Global Nesiritide Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bachem
6.1.1 Bachem Corporation Information
6.1.2 Bachem Description and Business Overview
6.1.3 Bachem Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bachem Nesiritide Drug Product Portfolio
6.1.5 Bachem Recent Developments/Updates
6.2 BCN Peptides
6.2.1 BCN Peptides Corporation Information
6.2.2 BCN Peptides Description and Business Overview
6.2.3 BCN Peptides Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BCN Peptides Nesiritide Drug Product Portfolio
6.2.5 BCN Peptides Recent Developments/Updates
6.3 Chengdu Kaijie Peptide
6.3.1 Chengdu Kaijie Peptide Corporation Information
6.3.2 Chengdu Kaijie Peptide Description and Business Overview
6.3.3 Chengdu Kaijie Peptide Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengdu Kaijie Peptide Nesiritide Drug Product Portfolio
6.3.5 Chengdu Kaijie Peptide Recent Developments/Updates
6.4 China Medical System
6.4.1 China Medical System Corporation Information
6.4.2 China Medical System Description and Business Overview
6.4.3 China Medical System Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China Medical System Nesiritide Drug Product Portfolio
6.4.5 China Medical System Recent Developments/Updates
6.5 Harbin Jixianglong Biotech
6.5.1 Harbin Jixianglong Biotech Corporation Information
6.5.2 Harbin Jixianglong Biotech Description and Business Overview
6.5.3 Harbin Jixianglong Biotech Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Harbin Jixianglong Biotech Nesiritide Drug Product Portfolio
6.5.5 Harbin Jixianglong Biotech Recent Developments/Updates
6.6 Hybio Pharmaceutical
6.6.1 Hybio Pharmaceutical Corporation Information
6.6.2 Hybio Pharmaceutical Description and Business Overview
6.6.3 Hybio Pharmaceutical Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hybio Pharmaceutical Nesiritide Drug Product Portfolio
6.6.5 Hybio Pharmaceutical Recent Developments/Updates
6.7 LeapChem
6.6.1 LeapChem Corporation Information
6.6.2 LeapChem Description and Business Overview
6.6.3 LeapChem Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LeapChem Nesiritide Drug Product Portfolio
6.7.5 LeapChem Recent Developments/Updates
6.8 Suzhou Tianma Pharma
6.8.1 Suzhou Tianma Pharma Corporation Information
6.8.2 Suzhou Tianma Pharma Description and Business Overview
6.8.3 Suzhou Tianma Pharma Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Suzhou Tianma Pharma Nesiritide Drug Product Portfolio
6.8.5 Suzhou Tianma Pharma Recent Developments/Updates
6.9 Xiamen Bam Biotech
6.9.1 Xiamen Bam Biotech Corporation Information
6.9.2 Xiamen Bam Biotech Description and Business Overview
6.9.3 Xiamen Bam Biotech Nesiritide Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Xiamen Bam Biotech Nesiritide Drug Product Portfolio
6.9.5 Xiamen Bam Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nesiritide Drug Industry Chain Analysis
7.2 Nesiritide Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nesiritide Drug Production Mode & Process
7.4 Nesiritide Drug Sales and Marketing
7.4.1 Nesiritide Drug Sales Channels
7.4.2 Nesiritide Drug Distributors
7.5 Nesiritide Drug Customers
8 Nesiritide Drug Market Dynamics
8.1 Nesiritide Drug Industry Trends
8.2 Nesiritide Drug Market Drivers
8.3 Nesiritide Drug Market Challenges
8.4 Nesiritide Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bachem
BCN Peptides
Chengdu Kaijie Peptide
China Medical System
Harbin Jixianglong Biotech
Hybio Pharmaceutical
LEAPChem
Suzhou Tianma Pharma
List of Tables
    Table 1. Global Nesiritide Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Nesiritide Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Nesiritide Drug Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Nesiritide Drug Sales (K Vials) of Key Manufacturers (2019-2024)
    Table 5. Global Nesiritide Drug Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Nesiritide Drug Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Nesiritide Drug Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Nesiritide Drug Average Price (US$/Vial) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Nesiritide Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Nesiritide Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Nesiritide Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Nesiritide Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nesiritide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nesiritide Drug as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Nesiritide Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Nesiritide Drug Sales by Region (2019-2024) & (K Vials)
    Table 18. Global Nesiritide Drug Sales Market Share by Region (2019-2024)
    Table 19. Global Nesiritide Drug Sales by Region (2025-2030) & (K Vials)
    Table 20. Global Nesiritide Drug Sales Market Share by Region (2025-2030)
    Table 21. Global Nesiritide Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Nesiritide Drug Revenue Market Share by Region (2019-2024)
    Table 23. Global Nesiritide Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Nesiritide Drug Revenue Market Share by Region (2025-2030)
    Table 25. North America Nesiritide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Nesiritide Drug Sales by Country (2019-2024) & (K Vials)
    Table 27. North America Nesiritide Drug Sales by Country (2025-2030) & (K Vials)
    Table 28. North America Nesiritide Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Nesiritide Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Nesiritide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Nesiritide Drug Sales by Country (2019-2024) & (K Vials)
    Table 32. Europe Nesiritide Drug Sales by Country (2025-2030) & (K Vials)
    Table 33. Europe Nesiritide Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Nesiritide Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Nesiritide Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Nesiritide Drug Sales by Region (2019-2024) & (K Vials)
    Table 37. Asia Pacific Nesiritide Drug Sales by Region (2025-2030) & (K Vials)
    Table 38. Asia Pacific Nesiritide Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Nesiritide Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Nesiritide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Nesiritide Drug Sales by Country (2019-2024) & (K Vials)
    Table 42. Latin America Nesiritide Drug Sales by Country (2025-2030) & (K Vials)
    Table 43. Latin America Nesiritide Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Nesiritide Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Nesiritide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Nesiritide Drug Sales by Country (2019-2024) & (K Vials)
    Table 47. Middle East & Africa Nesiritide Drug Sales by Country (2025-2030) & (K Vials)
    Table 48. Middle East & Africa Nesiritide Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Nesiritide Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Nesiritide Drug Sales (K Vials) by Type (2019-2024)
    Table 51. Global Nesiritide Drug Sales (K Vials) by Type (2025-2030)
    Table 52. Global Nesiritide Drug Sales Market Share by Type (2019-2024)
    Table 53. Global Nesiritide Drug Sales Market Share by Type (2025-2030)
    Table 54. Global Nesiritide Drug Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Nesiritide Drug Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Nesiritide Drug Revenue Market Share by Type (2019-2024)
    Table 57. Global Nesiritide Drug Revenue Market Share by Type (2025-2030)
    Table 58. Global Nesiritide Drug Price (US$/Vial) by Type (2019-2024)
    Table 59. Global Nesiritide Drug Price (US$/Vial) by Type (2025-2030)
    Table 60. Global Nesiritide Drug Sales (K Vials) by Application (2019-2024)
    Table 61. Global Nesiritide Drug Sales (K Vials) by Application (2025-2030)
    Table 62. Global Nesiritide Drug Sales Market Share by Application (2019-2024)
    Table 63. Global Nesiritide Drug Sales Market Share by Application (2025-2030)
    Table 64. Global Nesiritide Drug Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Nesiritide Drug Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Nesiritide Drug Revenue Market Share by Application (2019-2024)
    Table 67. Global Nesiritide Drug Revenue Market Share by Application (2025-2030)
    Table 68. Global Nesiritide Drug Price (US$/Vial) by Application (2019-2024)
    Table 69. Global Nesiritide Drug Price (US$/Vial) by Application (2025-2030)
    Table 70. Bachem Corporation Information
    Table 71. Bachem Description and Business Overview
    Table 72. Bachem Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 73. Bachem Nesiritide Drug Product
    Table 74. Bachem Recent Developments/Updates
    Table 75. BCN Peptides Corporation Information
    Table 76. BCN Peptides Description and Business Overview
    Table 77. BCN Peptides Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 78. BCN Peptides Nesiritide Drug Product
    Table 79. BCN Peptides Recent Developments/Updates
    Table 80. Chengdu Kaijie Peptide Corporation Information
    Table 81. Chengdu Kaijie Peptide Description and Business Overview
    Table 82. Chengdu Kaijie Peptide Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 83. Chengdu Kaijie Peptide Nesiritide Drug Product
    Table 84. Chengdu Kaijie Peptide Recent Developments/Updates
    Table 85. China Medical System Corporation Information
    Table 86. China Medical System Description and Business Overview
    Table 87. China Medical System Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 88. China Medical System Nesiritide Drug Product
    Table 89. China Medical System Recent Developments/Updates
    Table 90. Harbin Jixianglong Biotech Corporation Information
    Table 91. Harbin Jixianglong Biotech Description and Business Overview
    Table 92. Harbin Jixianglong Biotech Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 93. Harbin Jixianglong Biotech Nesiritide Drug Product
    Table 94. Harbin Jixianglong Biotech Recent Developments/Updates
    Table 95. Hybio Pharmaceutical Corporation Information
    Table 96. Hybio Pharmaceutical Description and Business Overview
    Table 97. Hybio Pharmaceutical Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 98. Hybio Pharmaceutical Nesiritide Drug Product
    Table 99. Hybio Pharmaceutical Recent Developments/Updates
    Table 100. LeapChem Corporation Information
    Table 101. LeapChem Description and Business Overview
    Table 102. LeapChem Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 103. LeapChem Nesiritide Drug Product
    Table 104. LeapChem Recent Developments/Updates
    Table 105. Suzhou Tianma Pharma Corporation Information
    Table 106. Suzhou Tianma Pharma Description and Business Overview
    Table 107. Suzhou Tianma Pharma Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 108. Suzhou Tianma Pharma Nesiritide Drug Product
    Table 109. Suzhou Tianma Pharma Recent Developments/Updates
    Table 110. Xiamen Bam Biotech Corporation Information
    Table 111. Xiamen Bam Biotech Description and Business Overview
    Table 112. Xiamen Bam Biotech Nesiritide Drug Sales (K Vials), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2019-2024)
    Table 113. Xiamen Bam Biotech Nesiritide Drug Product
    Table 114. Xiamen Bam Biotech Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Nesiritide Drug Distributors List
    Table 118. Nesiritide Drug Customers List
    Table 119. Nesiritide Drug Market Trends
    Table 120. Nesiritide Drug Market Drivers
    Table 121. Nesiritide Drug Market Challenges
    Table 122. Nesiritide Drug Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Nesiritide Drug
    Figure 2. Global Nesiritide Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Nesiritide Drug Market Share by Type in 2023 & 2030
    Figure 4. Purity Above or Equal to 99% Product Picture
    Figure 5. Purity Below 99% Product Picture
    Figure 6. Global Nesiritide Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Nesiritide Drug Market Share by Application in 2023 & 2030
    Figure 8. Treating Decompensated Heart Failure in Adults
    Figure 9. Treating Decompensated Heart Failure in Children
    Figure 10. Global Nesiritide Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Nesiritide Drug Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Nesiritide Drug Sales (2019-2030) & (K Vials)
    Figure 13. Global Nesiritide Drug Average Price (US$/Vial) & (2019-2030)
    Figure 14. Nesiritide Drug Report Years Considered
    Figure 15. Nesiritide Drug Sales Share by Manufacturers in 2023
    Figure 16. Global Nesiritide Drug Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Nesiritide Drug Players: Market Share by Revenue in 2023
    Figure 18. Nesiritide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Nesiritide Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Nesiritide Drug Sales Market Share by Country (2019-2030)
    Figure 21. North America Nesiritide Drug Revenue Market Share by Country (2019-2030)
    Figure 22. United States Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Nesiritide Drug Sales Market Share by Country (2019-2030)
    Figure 25. Europe Nesiritide Drug Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Nesiritide Drug Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Nesiritide Drug Revenue Market Share by Region (2019-2030)
    Figure 33. China Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Nesiritide Drug Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Nesiritide Drug Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Nesiritide Drug Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Nesiritide Drug Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Nesiritide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Nesiritide Drug by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Nesiritide Drug by Type (2019-2030)
    Figure 54. Global Nesiritide Drug Price (US$/Vial) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Nesiritide Drug by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Nesiritide Drug by Application (2019-2030)
    Figure 57. Global Nesiritide Drug Price (US$/Vial) by Application (2019-2030)
    Figure 58. Nesiritide Drug Value Chain
    Figure 59. Nesiritide Drug Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions